Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1.
Murugan, R.N., Park, J.E., Lim, D., Ahn, M., Cheong, C., Kwon, T., Nam, K.Y., Choi, S.H., Kim, B.Y., Yoon, D.Y., Yaffe, M.B., Yu, D.Y., Lee, K.S., Bang, J.K.(2013) Bioorg Med Chem 21: 2623-2634
- PubMed: 23498919 
- DOI: 10.1016/j.bmc.2013.02.020
- Primary Citation of Related Structures:  
4HAB, 4HY2 - PubMed Abstract: 
The polo-box domain (PBD) of polo-like kinase 1 (Plk1) is essentially required for the function of Plk1 in cell proliferation. The availability of the phosphopeptide-binding pocket on PBD provides a unique opportunity to develop novel protein-protein interaction inhibitors ...